These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 14664901)

  • 1. The DDAH/ADMA/NOS pathway.
    Tran CT; Leiper JM; Vallance P
    Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DDAH-ADMA-NOS pathway.
    Leiper JM
    Ther Drug Monit; 2005 Dec; 27(6):744-6. PubMed ID: 16404814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
    Achan V; Tran CT; Arrigoni F; Whitley GS; Leiper JM; Vallance P
    Circ Res; 2002 Apr; 90(7):764-9. PubMed ID: 11964368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F; Onozato ML; Luo Z; Wilcox CS
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
    Yin QF; Fu SH; He P; Xiong Y
    Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
    Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase.
    Böger RH; Vallance P; Cooke JP
    Atheroscler Suppl; 2003 Dec; 4(4):1-3. PubMed ID: 14664896
    [No Abstract]   [Full Text] [Related]  

  • 12. The biology and therapeutic potential of the DDAH/ADMA pathway.
    Arrigoni F; Ahmetaj B; Leiper J
    Curr Pharm Des; 2010; 16(37):4089-102. PubMed ID: 21247398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous inhibitors of nitric oxide and preeclampsia: a review.
    Slaghekke F; Dekker G; Jeffries B
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):447-52. PubMed ID: 16966108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase.
    Leiper J; Murray-Rust J; McDonald N; Vallance P
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13527-32. PubMed ID: 12370443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis.
    Fiedler LR; Wojciak-Stothard B
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1243-7. PubMed ID: 19909255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
    Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
    Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.